Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors-Reference-Cited by-同舟云学术

Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors

Published:2007-11-01 Issue:2 Volume:73 Page:338-348
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Emanuel Stuart L.,Hughes Terry V.,Adams Mary,Rugg Catherine A.,Fuentes-Pesquera Angel,Connolly Peter J.,Pandey Niranjan,Moreno-Mazza Sandra,Butler Jeannene,Borowski Virna,Middleton Steven A.,Gruninger Robert H.,Story Jennifer R.,Napier Cheryl,Hollister Beth,Greenberger Lee M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference45 articles.

1. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway.

2. c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function

3. Bohinski RC (1983) Modern Concepts in Biochemistry, 4th ed, pp 140-142, Allyn and Bacon, Boston.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking the ErbB pathway during adolescence affects the induction of anxiety-like behavior in young adult maternal immune activation offspring;Pharmacology Biochemistry and Behavior;2023-01

2. Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential;Biomolecules;2021-05-22

3. The Role of Structural Biology in Kinase Inhibitor Drug Discovery Success;Structural Biology in Drug Discovery;2020-01-02

4. ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2018-03

5. Constitutive loss and acute pharmacological manipulation of ErbB4 signaling do not affect attention and inhibitory control in mice;Genes, Brain and Behavior;2017-09-26